The MAPK-activated kinase Rsk controls an acute Toll-like receptor signaling response in dendritic cells and is

Rossana Zaru1, Natalia Ronkina, Matthias Gaestel

  • 1Division of Cell Biology and Immunology, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.

Nature Immunology
|October 2, 2007
PubMed

Insights

Mitogen-activated protein kinases (MAPKs) control dendritic cell (DC) Toll-like receptor (TLR) responses. This study reveals Rsk, a MAPK-activated kinase (MK), is crucial for TLR-driven DC endocytosis and activated by both Erk and p38 pathways.

Area of Science:

  • Immunology
  • Cell Biology
  • Signal Transduction

Background:

  • Dendritic cell (DC) activation by Toll-like receptor (TLR) ligands largely relies on mitogen-activated protein kinase (MAPK) signaling pathways.
  • The specific roles of MAPK-activated kinases (MKs) downstream of Erk and p38 in these DC responses remain largely uncharacterized.

Purpose of the Study:

  • To investigate the requirement of specific MKs in acute TLR-driven and MAPK-dependent DC endocytic responses.
  • To elucidate the upstream signaling pathways regulating MK activation in DCs.

Main Methods:

  • Utilized specific inhibitors targeting the MK Rsk to assess its role in TLR-induced endocytosis in DCs.
  • Investigated the activation configurations of the MAPK signaling system in DCs.

Main Results:

  • Inhibition of Rsk significantly suppressed TLR-induced endocytosis in DCs, establishing a critical role for MKs in TLR responses.
  • Identified a novel signaling mechanism where Rsk is activated by both Erk and p38 MAPKs in DCs.
  • Demonstrated that p38 MAPK, via intermediates MK2 and MK3, contributes to the activation of all known MK families in DCs.

Conclusions:

  • MAPK-activated kinases, particularly Rsk, are essential for TLR-mediated endocytosis in dendritic cells.
  • The p38 MAPK pathway plays a broader role in activating downstream MKs, including Rsk, in DCs than previously understood.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...